-
The last several years have brought unprecedented attacks on the publicly supported family planning effort in the United States.
-
Can increased use of the copper T intrauterine device (ParaGard IUD, Teva Womens Health, North Wales, PA) for emergency contraception (EC) make an impact on the rate of unplanned pregnancy at your clinic?
-
Human papillomavirus (HPV) might be to blame for the rise of young adults with oropharyngeal cancer.
-
-
This new evidence-based guidance from the CDC will improve and streamline how we provide contraceptive services to our patients, says Andrew Kaunitz, MD
-
An experimental levonorgestrel 20 mcg intrauterine device (LNG20 IUD) is under development by Medicines360, a San Francisco-based nonprofit pharmaceutical company.
-
Increasing the capacity of U.S. clinicians to provide high quality sexual and reproductive health (SRH) care for all Americans is an urgent public health priority, and proponents are working fast to implement new strategies to meet the need.
-
-
Integrating sexual and reproductive health (SRH) into public health and primary care is one of those vexing problems: complex, multifaceted, and requiring disparate groups to work together to develop strategies and policy activities that align pre-licensure SRH education, continuing professional development, and service delivery for all healthcare professionals within an integrated primary healthcare framework.
-
Good news: Recent data from the Centers for Disease Control and Prevention (CDC) show that teen birth rates fell at least 15% for all but two states (North Dakota and West Virginia) during 2007-2011, with rates falling 30% or more in seven states: Arizona, Colorado, Florida, Idaho, Minnesota, Nevada, and Utah.
